Agenus (Formerly known as Antigenics Inc. - Lexington, MA) Reports Second Quarter 2012 Financial Results

Published: Aug 02, 2012

LEXINGTON, Mass., Aug. 2, 2012 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN), a biotechnology company working to develop novel immunology-based treatments for cancers and infectious diseases, today reported its financial results and business and clinical highlights for the second quarter ended June 30, 2012.

Back to news